Ad is loading...
ADNRX vs RPMGX
ADNRX vs RPMGX Comparison
Open Charts ADNRX vs RPMGX
American Beacon ARK Transfmt Innov R6
Price$16.55
Change-$1.00 (-5.70%)
VolumeN/A
Net Assets195.39M
T. Rowe Price Mid-Cap Growth
Price$99.28
Change-$2.09 (-2.06%)
VolumeN/A
Net Assets29.49B
ADNRX vs RPMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. RPMGX commentary
Feb 23, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and RPMGX is a Hold.
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 29.5B vs. ADNRX (195M). RPMGX pays higher dividends than ADNRX: RPMGX (0.05) vs ADNRX (0.00). ADNRX was incepted earlier than RPMGX: ADNRX (4 years) vs RPMGX (33 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. RPMGX (21.70). ADNRX has a lower initial minimum investment than RPMGX: ADNRX (0) vs RPMGX (2500). ADNRX annual gain was more profitable for investors over the last year : 24.91 vs. RPMGX (-5.34).
| ADNRX | RPMGX | ADNRX / RPMGX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 33 years | - |
| Gain YTD | 6.158 | -0.451 | -1,365% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 195M | 29.5B | 1% |
| Annual Yield % from dividends | 0.00 | 0.05 | - |
| Returns for 1 year | 24.91 | -5.34 | -466% |
| Returns for 3 years | -11.07 | -1.07 | 1,039% |
| Returns for 5 years | N/A | 1.27 | - |
| Returns for 10 years | N/A | 25.08 | - |